CLOXACILLIN FOR INJECTION POWDER FOR SOLUTION

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Osta se nyt

Lataa Valmisteyhteenveto (SPC)
14-02-2019

Aktiivinen ainesosa:

CLOXACILLIN (CLOXACILLIN SODIUM)

Saatavilla:

STERIMAX INC

ATC-koodi:

J01CF02

INN (Kansainvälinen yleisnimi):

CLOXACILLIN

Annos:

10G

Lääkemuoto:

POWDER FOR SOLUTION

Koostumus:

CLOXACILLIN (CLOXACILLIN SODIUM) 10G

Antoreitti:

INTRAVENOUS

Kpl paketissa:

40ML

Prescription tyyppi:

Prescription

Terapeuttinen alue:

PENICILLINS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 0131306008; AHFS:

Valtuutuksen tilan:

MARKETED

Valtuutus päivämäärä:

2013-04-03

Valmisteyhteenveto

                                1
PRESCRIBING INFORMATION
PR
CLOXACILLIN FOR INJECTION
Cloxacillin Powder for Solution (as cloxacillin sodium)
500mg powder/vial
1g powder/vial
2g powder/vial
10g powder/vial
STERILE
ANTIBIOTIC
SteriMax Inc.
2770 Portland Drive,
Oakville, ON
L6H 6R4
Date of Revision:
February 14, 2019
CONTROL NUMBER: 221983
2
TABLE OF CONTENTS
PART 1: HEALTH PROFESSIONAL INFORMATION
………………………......
3
SUMMARY PRODUCT
INFORMATION……………………………………...
3
INDICATIONS AND CLINICAL
USE…………………………………………
3
CONTRAINDICATIONS……………………………………………………….
3
WARNINGS AND
PRECAUTIONS……………………………………………
4
ADVERSE
REACTIONS………………………………………………………..
5
DRUG
INTERACTIONS………………………………………………………...
5
DOSAGE AND
ADMINISTRATION…………………………………………..
5
OVERDOSAGE………………………………………………………………….
7
ACTIONS AND CLINCAL PHARMACOLOGY………………………………
7
STORAGE AND
STABILITY…………………………………………………...
8
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..
8
PART II: SCIENTIFIC INFORMATION
...................................................................
9
PHARMACEUTICAL
INFORMATION………………….............…….............
9
PART III: CONSUMER INFORMATION
..................................................................
10
3
PRESCRIBING INFORMATION
PR
CLOXACILLIN FOR INJECTION
CLOXACILLIN POWDER FOR SOLUTION (AS CLOXACILLIN SODIUM)
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM /
STRENGTH
CLINICALLY RELEVANT NON-MEDICINAL
INGREDIENTS
IV, IM, IV Infusion
Powder for
reconstitution for
INJECTION
None
INDICATIONS AND CLINICAL USE
The treatment of beta-hemolytic streptococcal and pneumococcal
infections as well as
staphylococcal infections (inc
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Valmisteyhteenveto Valmisteyhteenveto ranska 14-02-2019

Etsi tähän tuotteeseen liittyviä ilmoituksia